ArticleCNS drugs2018

Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.

Patricia Del Cerro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.